Astragaloside IV ameliorates metabolic disorder in db/db obese mice as a PPARγ antagonist-Reference-Cited by-同舟云学术

Astragaloside IV ameliorates metabolic disorder in db/db obese mice as a PPARγ antagonist

Published:2022-07-22 Issue:5 Volume:25 Page:484-496
ISSN:1028-6020
Container-title:Journal of Asian Natural Products Research
language:en
Short-container-title:Journal of Asian Natural Products Research

Author:

Wu Hui¹,Wang Gao-Rui¹,Wang Xin-Ting²,Bai Yu-Yan¹,Yuan Jin-Feng¹,Yang Liu¹,Huang Fei¹,Shi Hai-Lian¹,Wu Xiao-Jun¹

Affiliation:

1. Shanghai Key Laboratory of Compound Chinese Medicines, The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China

2. Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China

Funder

Xinglin Young Talent Program in Shanghai University of Traditional Chinese Medicine

Educational Commission of Shanghai in China

Publisher

Informa UK Limited

Subject

Organic Chemistry,Complementary and alternative medicine,Drug Discovery,Pharmaceutical Science,Pharmacology,Molecular Medicine,General Medicine,Analytical Chemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/10286020.2022.2098726

Reference25 articles.

1. PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

2. PPAR gamma gene – A review

3. PPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development

4. Ectopic overexpression of adipogenic transcription factors induces transdifferentiation of MC3T3-E1 osteoblasts

5. Nuclear Receptors in Lipid Metabolism: Targeting the Heart of Dyslipidemia

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Astragaloside IV attenuates fatty acid-induced renal tubular injury in diabetic kidney disease by inhibiting fatty acid transport protein-2;Phytomedicine;2024-11

2. The Natural Products as Novel Anti-obesity Agents: Mechanisms Based on Adipose Tissue;Current Diabetes Reviews;2024-02-23

3. Qiliqiangxin: A multifaceted holistic treatment for heart failure or a pharmacological probe for the identification of cardioprotective mechanisms?;European Journal of Heart Failure;2023-11-14